Cargando…
Regulatory approval pathway for COVID-19 vaccine in USA, Europe and India
The coronavirus disease-2019 (COVID-19) outbreak has confused everyone, including healthcare experts, physicians and frontline workers. Monoclonal antibodies, anticoagulants and immunomodulatory therapy were initially used to treat COVID-19. However, they can only inhibit the virus from replicating,...
Autores principales: | Narasimhan, Jaipratap, Maanvizhi, Saba |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129106/ https://www.ncbi.nlm.nih.gov/pubmed/37113820 http://dx.doi.org/10.1097/MS9.0000000000000000 |
Ejemplares similares
-
On the Regulatory Approval Pathway of Biosimilar Products
por: Wang, Jun, et al.
Publicado: (2012) -
Characteristics of non-randomised studies using comparisons with external controls submitted for regulatory approval in the USA and Europe: a systematic review
por: Goring, Sarah, et al.
Publicado: (2019) -
The Vernakalant Story: How Did It Come to Approval in Europe and What is the Delay in the U.S.A?
por: A, John Camm MD
Publicado: (2014) -
Review on Approved and Inprogress COVID-19 Vaccines
por: Farnudian-Habibi, Amir, et al.
Publicado: (2022) -
Regulatory approval of COVID-19 vaccine for restricted use in clinical trial mode
por: Mohapatra, Prasanta Raghab, et al.
Publicado: (2021)